Week 512 Review - Optibiotix and Jubilee Metals continue to drag me down.

The week started off OK, but then JLP:Jubilee Metals released what I thought was good news confirming copper grade rates, but it tanked the share price, and OPTI:Optibiotix dropped too, so it ended up a miserable week with the deficit between cost and value growing by £2,835 to £131,068 and between injection and value growing to £57,461. Total portfolio value dropped to £113,751.

Biggest loser was my 2nd largest holding JLP:Jubilee Metals, which dropped 12% and I really don't understand why. There was nothing negative in the update - just what we expected. It's taking a hell of a long time for the market to recognise this.

FXPO:Ferrexpo tanked by 10% but tragically at 89% down, I still have to report on it for another week.

AFC:AFC Energy gave up some of the recent gains and dropped 7%. They are 51% down, which isn't bad given where they have been.

I'd already written the intro before going through the performances of each share. To my surprise, this was a much better week than I thought for most of the portfolio.

CAML:Central Asia Metals, FOUR:4imprint and TRY:TR Property Investment all went up 5%.

ALPH:Alpha Group, ASHM:Ashmore Group, GSK:GSK and TLOU:Tlou Energy all went up 6%.

ATYM:Atalaya Mining went up 7% and are only 1% down.

CWR:Ceres Power did the opposite to AFC:AFC Energy and went up 13%.

Share of the Week is PBX:Probiotix Health which went up 15% after decent results.

Here's the ISA and shares portfolio after week 44 of year 10.

			Weekly Change
Cash	£153.02		+£0
Portfolio cost	£114,352.47		+£0
Portfolio sell value (bid price-commission)	£42,902.28	(-62.5%)	-£1,807.06
Potential profits	£0		+£0
Yr 10 Dividends	£180.12		+£0
Yr 10 Interest	£1.11		+£0
Yr 10 Profit from sales	£327.55		+£0
Yr 10 proj avg monthly profit	£42.01	(0.6%)	-£0.97
Total Dividends	£12,488.07		+£0
Total Interest	£7.91		+£0
Total Profit from sales	£17,602.85		+£0
Average monthly cash profit	£250.09	(3.5%)	-£0.49
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	35%		+0%

Very little happened apart from the huge drop in value.

Almost back down to worst ever.

Touching the trend line and very close to biggest ever losses.

The SIPP looks like this after week 496 overall and week 28 of year 10.

			Weekly Change
Cash	£601.95		+£65.73
Portfolio cost	£129,712.16		+£0
Portfolio sell value (bid price - commission)	£70,094.07	(-46.0%)	-£1,028.68
Potential profits	£5,873.70		-£500.17
Yr 10 Dividends	£1,004.75		+£65.73
Yr 10 Interest	£2.23		+£0
Yr 10 Profit from sales	£2,375.87		+£0
Yr 10 proj avg monthly profit	£504.93	(7.0%)	-£8.15
Total Dividends	£17,121.40		+£65.73
Total Interest	£15.13		+£0
Total Profit from sales	£19,383.81		+£0
Average monthly cash profit	£305.94	(4.3%)	-£0.05
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+0%

I got £27 dividend from ARBB:Arbuthnot Banking, £12 from BPM:BP Marsh, and £25 from UKW:Greencoat UK Wind. Potential profits dropped £500 and value didn't drop as much as the ISA, but it was more than £1,000.

I keep adding more money and it just won't go up.

As with the ISA, touching the trend line and still heading downwards on a very long slow decline.

I've got a holiday to pay for so will be removing cash from my account for the first time in ages, and of course selling for a loss because nothing in the ISA or dealing account is in the black.

I'm just treading water until something happens for JLP:Jubilee Metals. Everything else is either massively in loss or a long-term holding. I need JLP to do something to help me break out of this interminable decline.

Week 511 Review - Jubilee Metals shines, but all is ruined by an Optibiotix discounted placing.

It was all looking so wonderful on Thursday, despite most of the portfolio being down. A big surge in JLP:Jubilee Metals saw value up by about £3.5k. However a discounted placing by OPTI:Optibiotix on Friday obliterated all that and we end the week down by £3,425. The deficit between cost and value is now £128,232 and between injection and value is £54,691. Portfolio value has dropped to £116,521.

Biggest faller was OPTI:Optibiotix, tanking 17% due to the placing being at a 20% discount. If the institution were so keen to invest, why couldn't they pay the 18p share price? The drop cost me over £6,000 so it's a good job other shares baled me out a bit,

I spoke too soon last week when I suggested the Hydrogen companies were recovering, as CWR:Ceres Power dropped 15% this week to go 71% down.

Similarly, AFC:AFC Energy dropped 7% to go 48% down.

FDM:FDM Group also dropped 7% after an AGM statement saying things are still a bit tough.

FXPO:Ferrexpo continue to bounce around, and dropped 7% this week but are still only 88% down so I still have to report on them.

SCT:Softcat dropped 5% for no obvious reason, but are still 6% in profit.

IPX:Impax Asset Management have been creeping back lately, with another 5% rise this week after reasonable interim results and announcing a share buy-back scheme.

PAF:Pan African Resources got hammered last week, but recovered 9% of those losses to go 66% up.

Share of the Week by a mile is JLP:Jubilee Metals which went up 14% just a week after going up 13%, taking some of my SIPP holdings into profit. Platinum prices are rising, so they are likely to start processing the huge tailings stockpile, and we should get results on the copper grades next week. That's the danger point - JLP have a habit of shooting themselves in the foot - I'm nervous!

Here's the ISA and shares portfolio after week 43 of year 10.

			Weekly Change
Cash	£153.02		+£32.85
Portfolio cost	£114,352.47		+£0
Portfolio sell value (bid price-commission)	£44,709.34	(-60.9%)	-£1,709.82
Potential profits	£0		+£0
Yr 10 Dividends	£180.12		+£32.85
Yr 10 Interest	£1.11		+£0
Yr 10 Profit from sales	£327.55		+£0
Yr 10 proj avg monthly profit	£42.98	(0.6%)	+£2.36
Total Dividends	£12,488.07		+£32.85
Total Interest	£7.91		+£0
Total Profit from sales	£17,602.85		+£0
Average monthly cash profit	£250.58	(3.5%)	-£0.21
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	35%		+0%

Cash went up thanks to a £32 CAML:Central Asia Metals dividend, but OPTI:Optibiotix tanked the portfolio.

Sliding downwards again.

Still above the trend line but following it down.

The SIPP looks like this after week 495 overall and week 27 of year 10.

			Weekly Change
Cash	£536.22		+£421.04
Portfolio cost	£129,712.16		+£0
Portfolio sell value (bid price - commission)	£71,122.75	(-45.2%)	-£1,715.82
Potential profits	£6,373.87		+£882.27
Yr 10 Dividends	£939.02		+£283.54
Yr 10 Interest	£2.23		+£0
Yr 10 Profit from sales	£2,375.87		+£0
Yr 10 proj avg monthly profit	£513.08	(7.2%)	+£27.53
Total Dividends	£17,055.67		+£283.54
Total Interest	£15.13		+£0
Total Profit from sales	£19,383.81		+£0
Average monthly cash profit	£305.99	(4.3%)	+£1.87
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	41%		+1%

Cash went up £421 thanks to a tax rebate, and £272 dividend from CAML:Central Asia Metals, £5 from ALPH:Alpha Group, and £5 from SCT:Softcat. I love getting the CAML dividend! They announced a new purchase in USA this week and it hardly touched the share price, which is massively undervalued. Potential profits soared by £882 thanks to PAF:Pan African Resources and JLP:Jubilee Metals.

Direction well and truly changed and momentum lost.

Almost touching the trend line. Grim.

Well another defeat dragged from the jaws of victory. On Thursday the portfolio value was finally more than the deficit, but not any more.

My only hope for next week is that the reasons for the OPTI:Optibiotix placing are explained and the price drifts back up to the 17.5p from last week, as there some positives in the RNS. Given Slimbiome was meant to be the side product while SweetBiotix led the way, it seems Slimbiome is increasing sales worldwide and might not need SweetBiotix to do anything. Given so far it hasn't, then we may need Slimbiome.

Meanwhile JLP:Jubilee Metals had a bad day on Friday, losing some of the gains from the rest of the week. This has sparked fears the seller is not quite done. We'll see what happens next week. I'm nervous but excited too.

Week 510 Review - Jubilee Metals may have finally woken up.

Not a bad week, despite OPTI:Optibiotix dropping 0.5p, The deficit between cost and value narrowed by £1,018 to £124,806 and the deficit between injection and value reduced to £51,720. Total portfolio value increased to £119,493.

Worst performer was PAF:Pan African Resources which gave up most of last week's gains. Gold hasn't dropped 13% in price so I don't know why these have.

III:3i Group fell 5% in a rare pullback for my most successful investment.

SBTX:SkinBioTherapeutics fell yet another 5% as there is still no news on anyone using their lysate.

AFC:AFC Energy had another good week, climbing 6% to go 44% down.

IPX:Impax Asset Management recovered another 7% but are 62% down.

AJB:AJ Bell went up 9% and they are bow 58% in profit.

CWR:Ceres Power had another good week as maybe hydrogen shares are being given another chance. They are still 66% down.

FOUR:4imprint plummeted after a lukewarm future looking statement a few months ago, but recovered 13% this week and are now 35% down.

Share of the Week is JLP:Jubilee Metals, which also went up 13% but is a way larger holding and one I've been waiting to turn around for two years.

Here's the ISA and shares portfolio after week 42 of year 10.

			Weekly Change
Cash	£120.17		+£0.85
Portfolio cost	£114,352.47		+£0
Portfolio sell value (bid price-commission)	£46,419.16	(-59.4%)	+£688.98
Potential profits	£0		+£0
Yr 10 Dividends	£147.27		+£8.93
Yr 10 Interest	£1.11		+£0.02
Yr 10 Profit from sales	£327.55		+£0
Yr 10 proj avg monthly profit	£40.62	(0.6%)	-£0.90
Total Dividends	£12,455.22		+£8.93
Total Interest	£7.91		+£0.02
Total Profit from sales	£17,602.85		+£0
Average monthly cash profit	£250.79	(3.5%)	-£0.48
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	35%		+0%

Most of the £688 rise is thanks to JLP:Jubilee Metals, which is my 2nd biggest holding in the ISA. I also got an £8 dividend from CAPD:Capital.

I'm doing the write-up on my laptop, which makes the charts gigantic at original size, so I had to use "Large" which naturally means they are smaller.

Almost back to where we were last week.

The SIPP looks like this after week 494 overall and week 26 of year 10.

			Weekly Change
Cash	£115.18		-£239.71
Portfolio cost	£129,712.16		+£231.11
Portfolio sell value (bid price - commission)	£72,838.57	(-43.8%)	+£329.27
Potential profits	£5,491.60		-£560.79
Yr 10 Dividends	£655.48		+£10.98
Yr 10 Interest	£2.23		+£0.11
Yr 10 Profit from sales	£2,375.87		+£0
Yr 10 proj avg monthly profit	£485.55	(6.8%)	-£20.92
Total Dividends	£16,772.13		+£10.98
Total Interest	£15.13		+£0.11
Total Profit from sales	£19,383.81		+£0
Average monthly cash profit	£304.12	(4.2%)	-£0.69
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	40%		+0%

I did my monthly investment, buying 12 shares in BHP:BHP Group at 1913.44p costing £231.11. I despair at how often the price of my monthly investment soars just before I invest, then sinks straight after, It's almost fishy. That's all my BHP shares bought now, so I'm switching to FOUR:4imprint as I like them and think they are cheap.

The value didn't go up as much as the ISA as it has fewer JLP:Jubilee Metals. Potential profits dropped £560 largely due to PAF:Pan African Resources.

I got £10 dividends from from CAPD:Capital and 11p interest.

Flattish again

No longer parallel to the trend line, but not exactly zooming upwards.

Good to have caught up, but already half way through week 511. Happy to say that so far JLP:Jubilee Metals is continuing to climb. Could the big sellers have finally cleared out and given us a chance to recover?

Week 509 Review - First down week for a while.

Not a bad week for most of the portfolio, but a 1.5p drop for OPTI:Optibiotix and another big drop for SBTX:SkinBioTherapeutix means the first down week for a while, with the deficit between cost and value widening by £2,158 to £125,825 and the deficit between injection and value widened to £52,730. Total portfolio value dropped to £118,482.

Worst performer was FXPO:Ferrexpo, dropping 21%, although beats me why it went up in the first place. Unfortunately it's only 87% down so I still have to report on it.

OPTI:Optibiotix dropped 8% and was the main reason my portfolio ended the week down. There is unrest among shareholders which isn't helping things one bit.

BPM:BP Marsh & Partners dropped 7% on the back of a significant institutional investor dumping a big portion of its holding in a placing at a discount.

GSK:GSK dropped 5%, presumably on tariff fears.

TLOU:Tlou Energy fell 5% and seems to be drifting down until we get some positive news.

ALU:Alumasc Group and SCT:Softcat both went up 5%, and are both in-profit magic formula shares.

IPX:Impax Asset Management went up 7%, but these are still down 64%.

ALPH:Alpha Group went up 11% after news someone wants to buy them.

PAF:Pan African Resources went up 13% as gold soared, and they are now 74% up.

CWR:Ceres Power went up 15% but are still 69% down.

Share of the Week is AFC:AFC Energy which zoomed up 17%, maybe due to closing shorts, but they are still 47% down.

Here's the ISA and shares portfolio after week 41 of year 10.

			Weekly Change
Cash	£119.32		+£0
Portfolio cost	£114,352.47		+£0
Portfolio sell value (bid price-commission)	£45,730.18	(-60.0%)	-£1,736.33
Potential profits	£0		-£58.72
Yr 10 Dividends	£138.34		+£0
Yr 10 Interest	£1.09		+£0
Yr 10 Profit from sales	£327.55		+£0
Yr 10 proj avg monthly profit	£41.52	(0.6%)	-£1.04
Total Dividends	£12,446.29		+£0
Total Interest	£7.89		+£0
Total Profit from sales	£17,602.85		+£0
Average monthly cash profit	£251.27	(3.5%)	-£0.50
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	35%		+0%

Most of the drop in value is OPTI:Optibiotix, and as SBTX:SkinBioTherapeutics collapses, all my potential profits are wiped out - again,

I knew it was too good to last.

Still above the trend line, but not enough to start dragging it up.

The SIPP looks like this after week 493 overall and week 25 of year 10.

			Weekly Change
Cash	£354.89		+£11.00
Portfolio cost	£129,481.05		+£0
Portfolio sell value (bid price - commission)	£72,278.19	(-44.2%)	-£422.44
Potential profits	£6,052.39		+£951.24
Yr 10 Dividends	£644.50		+£11.00
Yr 10 Interest	£2.12		+£0
Yr 10 Profit from sales	£2,375.87		+£0
Yr 10 proj avg monthly profit	£506.47	(7.1%)	-£19.11
Total Dividends	£16,761.15		+£11.00
Total Interest	£15.02		+£0
Total Profit from sales	£19,383.81		+£0
Average monthly cash profit	£304.81	(4.3%)	-£0.52
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	40%		+0%

I got an £11 dividend from from GAW:Games Workshop, and losses are only £422 thanks to big rises in some of my magic formula shares, resulting in potential profits rising £951.

That's almost flat.

Same angle as the trend line, and perilously close to it.

I'm 2 weeks late writing this so nothing else to say.

Week 508 Review - A good week slightly spoiled by a big drop in SkinBioTherapeutics.

A pretty good week, with most shares up. A few major holdings were down, which lowered the gains to a £2,873 reduction in the deficit between cost and value to £123,666 and a reduction in deficit between injection and value to £50,582. Total portfolio value increased to £120,630.

Worst performer was SBTX:SkinBioTherapeutics which dropped 13%, but that was on the back of a 24% rise last week. It hammered my ISA potential profits though, dropping from £847 to £58.

Fellow microbiome share PBX:Probiotix Health had a second bad week in a row, dropping 7%, with most of my holding now down 68%.

TRX:Tissue Regenix continued the relentless slide and dropped another 6% to go 77% down. I'm so glad they announced they were thinking of selling the company which has generated a 50% drop in value since.

The rest was good news. There were no real reasons for most of the increases as far as I could see.

ALPH:Alpha Group went up 5% and my holding is now 11% in profit. Interesting that an after hours RNS stated a company is interested in buying them, so it looks like I won't get a chance to hold them for long. The question is, how much are they willing to pay? If it's more than the current share price at least I'll come away with some profit, but not the years of dividends I was hoping for.

IPX:Impax Asset Management also went up 5% but are down 67% altogether, which is way too much in my opinion and I wish I had money on the SIPP to buy some more. I will have if JLP:Jubilee Metals ever sort themselves out.

ARBB:Arbuthnot Banking went up 6% and POLR:Polar Capital went up 7%.

ATYM:Atalaya Mining, FDM:FDM Group, OPTI:Optibiotix , PSN:Persimmon and SCT:Softcat all went up 8%, and ATYM is being added to the FTSE250 which should help the share price - although it didn't do much good for CWR:Ceres Power.

AFC:AFC Energy went up a massive 33% which I suspect is shorters closing their bets, as nothing really happened. I'm still down 55% but it's a lot less horrifying than it was last week.

Share of the Week is FXPO:Ferrexpo, which I stated I wouldn't have to report on any more as they were bound to go back to 90% down, but I was wrong as they went up another 42% and are now 84% down. I don't know why they went up as their situation doesn't seem to have improved at all.

Here's the ISA and shares portfolio after week 40 of year 10.

			Weekly Change
Cash	£119.32		+£0
Portfolio cost	£114,352.47		+£0
Portfolio sell value (bid price-commission)	£47,466.51	(-58.5%)	+£756.66
Potential profits	£58.72		-£788.44
Yr 10 Dividends	£138.34		+£0
Yr 10 Interest	£1.09		+£0
Yr 10 Profit from sales	£327.55		+£0
Yr 10 proj avg monthly profit	£42.56	(0.6%)	-£1.09
Total Dividends	£12,446.29		+£0
Total Interest	£7.89		+£0
Total Profit from sales	£17,602.85		+£0
Average monthly cash profit	£251.77	(3.5%)	+£0.50
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	35%		+0%

The increase would have been twice as much without the big drop in SBTX:SkinBioTherapeutics, which obliterated my potential profits.

Still below where we were when the tariff debacle hit.

A little bit further above the trend line, but it's going to be pointing downwards for a long time yet.

The SIPP looks like this after week 492 overall and week 24 of year 10.

			Weekly Change
Cash	£343.89		+£250.00
Portfolio cost	£129,481.05		+£0
Portfolio sell value (bid price - commission)	£72,700.63	(-43.9%)	+£2,116.40
Potential profits	£5,101.15		+£260.48
Yr 10 Dividends	£633.50		+£0
Yr 10 Interest	£2.12		+£0
Yr 10 Profit from sales	£2,375.87		+£0
Yr 10 proj avg monthly profit	£525.58	(7.3%)	-£22.85
Total Dividends	£16,750.15		+£0
Total Interest	£15.02		+£0
Total Profit from sales	£19,383.81		+£0
Average monthly cash profit	£305.33	(4.3%)	-£0.63
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	40%		+0%

I added £250 for my monthly investment but the trade won't be until next week. Healthy increase in value and modest rise in potential profits.

This account is a little higher than it was on tariff day.

Above the trend line, and back to the relatively stable position this account has held for the last six months aside from a few brief blips.

There's speculation that the seller responsible for keeping the JLP:Jubilee Metals share price down is the mining company we bought the high grade copper supply from. It makes sense that they would want to convert them to cash straight away if they are short of cash themselves, although it does seem very short sighted. It would be nice not to be in the grips of a big seller just for a little while. Long enough to sell a load of my SIPP holding as I only need 5.5p to start selling, from the current 3.1p we've held at for a few weeks. If it can get to 11.5p then my entire SIPP holding of 277,591 shares will be sold, leaving me with 335,780 in the ISA which I'll keep. There are also 45,497 in the dealing account from my old trading account which I'll be pulling out as cash, but they need the price to be 11.5p and 14p.

Week 507 Review - Flat week but SkinBioTherapeutics may be on a break out.

Generally a flat week, with my two largest holdings not moving, but gains and losses in other big holdings. The deficit between cost and value improved by £660 to £126,539 and the deficit between injection and value reduced to £53,455. Total portfolio value increased to £117,507.

The worst performer was PBX:Probiotix Health, which dropped 1p and 13%. The price seems to be drifting slowly downwards after some brief optimism a few months ago.

PAF:Pan African Resources fell 7% which was presumably profit taking after the recent strong run, as gold is still very high.

TRX:Tissue Regenix continued the recent slide and fell by another 6% to go 76% down.

TLOU:Tlou Energy has been showing some weird prices on ASX, so I've stopped using the bid price and reverted to share price due to the bid price being shown as ludicrously low. As a result the price went up 26% on paper, but is actually the same as last week.

APAX:Apax Global Alpha had a slight recovery, gaining 5% to go 37% down. Not a great performance from this previously strong magic formula share, but worth holding for the great dividend in the hope the price will recover.

CWR:Ceres Power has been all over the place lately, but went up 5% this week. They are 74% down, which is not what I was expecting when they listed on the main market and briefly went into the FTSE 250. I blame massive shorting for the share price drop.

FOUR:4imprint do quite a lot of business in America which may explain the recent collapse in share price, but I don't see how tariffs will impact them. The main drop followed record profits but a note of caution with an uncertain economic outlook. They have £147 million cash so it doesn't seem that uncertain. They recovered 6% this week but are still 41% down. I would buy more if I had cash.

ASHM:Ashmore Group went up 9% for no discernible reason but they are still 50% down. I've had £140 dividends though, so they seem to be doing OK. They are in my dealing account so I'll sell them as soon as I'm not making a huge loss, which may be some time.

FXPO:Ferrexpo continue to bounce up and down and went up 9% this week which unfortunately means they are 89% down and I have to start reporting on them again, until next week when they no doubts go back over 90% down.

Share of the Week is SBTX:SkinBioTherapeutics which went up 24% and sent my ISA holding into profit by 17%. There does seem to be genuine hope for the new ingredient launched this month by Croda, with standing ovations at the launch event. If they keep climbing then maybe there will be a knock-on for OPTI:Optibiotix who still own 10% of the shares.

Here's the ISA and shares portfolio after week 39 of year 10.

			Weekly Change
Cash	£119.32		+£0
Portfolio cost	£114,352.47		+£0
Portfolio sell value (bid price-commission)	£46,709.85	(-59.2%)	+£1,015.96
Potential profits	£847.16		+£847.16
Yr 10 Dividends	£138.34		+£0
Yr 10 Interest	£1.09		+£0
Yr 10 Profit from sales	£327.55		+£0
Yr 10 proj avg monthly profit	£43.65	(0.6%)	-£1.14
Total Dividends	£12,446.29		+£0
Total Interest	£7.89		+£0
Total Profit from sales	£17,602.85		+£0
Average monthly cash profit	£252.27	(3.6%)	+£0.49
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	35%		+0%

I have a big SBTX:SkinBioTherapeutix holding in the ISA, so most of the £1,015 increase is thanks to that, plus potential profits going from nothing to £847 is all down to SBTX.

Pretty flat for 6 months now.

Above the trend line but for how long?

Nearly a year since I sold anything.

The SIPP looks like this after week 491 overall and week 23 of year 10.

			Weekly Change
Cash	£93.89		-£62.63
Portfolio cost	£129,481.05		+£287.63
Portfolio sell value (bid price - commission)	£70,584.23	(-45.5%)	-£355.03
Potential profits	£4,840.67		-£128.79
Yr 10 Dividends	£633.50		+£0
Yr 10 Interest	£2.12		+£0
Yr 10 Profit from sales	£2,375.87		+£0
Yr 10 proj avg monthly profit	£548.43	(7.7%)	-£24.93
Total Dividends	£16,750.15		+£0
Total Interest	£15.02		+£0
Total Profit from sales	£19,383.81		+£0
Average monthly cash profit	£305.96	(4.3%)	-£0.62
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	40%		+0%

I had some tax rebates in both my AJ Bell and Hargreaves Lansdown accounts so bought a few more JLP:Jubilee Metals shares in anticipation of copper production news being imminent and hopefully giving the share price a boost. 

I bought 3,858 in my AJ Bell account at 3.24p costing £130 and 4,455 in my Hargreaves Lansdown account at 3.27p costing £157.63. Needless to say they dropped shortly afterwards and are 3.1p to sell. Hopefully next week my relentless buying will finally be rewarded, although so far whenever I relentlessly buy something it seems to do worse.

Portfolio value actually dropped by £355 and potential profits by £128 largely thanks to the big drop in PAF:Pan African Resources and the small number of SBTX:SkinBioTherapeutics shares in my SIPP.

Value flat but costs going up.

Right on the trend line. I remember the days when my SIPP performance was much better than my ISA, but not any more.

Still hoping for some big JLP:Jubilee Metals sells in the not to distant future to improve the look of this. At least it's better now than it was 12 months ago, most of which was selling part of my PAF:Pan African Resources holding.

Week 506 Review - Great week sees us almost back to pre-tariff value.

A great week for most shares in my portfolio, including my largest holdings. The deficit between cost and value narrowed by £8,424 to £127,200 and the deficit between injection amount and value reduced to £54,291. Total portfolio value increased to £116,621, which is almost back to where it was before Trump announced his tariffs. However, the gains are largely due to my larger holdings and not so much my magic formula shares, many of which which are still down since the tariff announcements.

The only share that dropped significantly was TLOU:Tlou Energy which fell 28%, but I suspect this is a false drop, as ASX does odd things with the bid price. It will likely bounce back next week.

CAML:Central Asia Metals, GAW:Games Workshop, III:3i Group and PAGE:Pagegroup all climbed 6%.

APAX:Apax Global Alpha, IPX:Impax Asset Management, JLP:Jubilee Metals and TRY:TR Property Investment all went up by 7%.

ALPH:Alpha Group went up 9% and are back in profit by 1%.

PSN:Persimmon also went up 9% but are still 17% down.

SBTX:SkinBioTherapeutics recovered 11% so my ISA holding is only down by 6% now.

ATYM:Atalaya Mining went up 14% after a good production update.

Share of the Week is OPTI:Optibiotix, who announced a new US deal for Slimbiome which could be a big one and went up 16% in response. We are getting some bigger Slimbiome deals these days, so if they can just generate some decent revenue, then any SweetBiotix announcement will be the icing on the cake.

Here's the ISA and shares portfolio after week 38 of year 10.

			Weekly Change
Cash	£119.32		-£4.34
Portfolio cost	£114,352.47		+£0
Portfolio sell value (bid price-commission)	£45,693.89	(-60.0%)	+£3,858.29
Potential profits	£0		+£0
Yr 10 Dividends	£138.34		+£0
Yr 10 Interest	£1.09		+£0.03
Yr 10 Profit from sales	£327.55		+£0
Yr 10 proj avg monthly profit	£44.79	(0.6%)	-£1.72
Total Dividends	£12,446.29		+£0
Total Interest	£7.89		+£0.03
Total Profit from sales	£17,602.85		+£0
Average monthly cash profit	£252.76	(3.6%)	+£0.54
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	35%		+0%

Cash dropped a little due to AJ Bell fees and value soared. Nothing else happened.

Boing.

Back above the trend line.

The SIPP looks like this after week 490 overall and week 22 of year 10.

			Weekly Change
Cash	£156.52		+£27.21
Portfolio cost	£129,193.42		+£0
Portfolio sell value (bid price - commission)	£70,651.63	(-45.3%)	+£4,566.28
Potential profits	£4,969.46		+£366.49
Yr 10 Dividends	£633.50		+£29.92
Yr 10 Interest	£2.12		+£0.11
Yr 10 Profit from sales	£2,375.87		+£0
Yr 10 proj avg monthly profit	£573.36	(8.0%)	-£21.69
Total Dividends	£16,750.15		+£29.92
Total Interest	£15.02		+£0.11
Total Profit from sales	£19,383.81		+£0
Average monthly cash profit	£306.58	(4.3%)	-£0.39
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	40%		+0%

I had a £29 dividend from RIO:Rio Tinto minus AJ Bell fees, value went up more than the ISA, and potential profits increased by £366.

Keeping pace with the injection line but not getting close enough for my liking.

A big jump, but only enough to touch the injection line.

JLP:Jubilee Metals announced great production results from South Africa but there's still a seller keeping the price down. The big news will be copper production in Zambia, which should be due soon. Even with a big seller, that could send the price significantly higher. I wish it would, as I really want to sell the SIPP shares and put them into magic formula shares while prices are still depressed.

Meanwhile there's a bit more optimism at OPTI:Optibiotix, so could we get a gradual and sustained recovery back to the 40p level? I think that's where we should be right now, and it would put me almost back on the injection line.